Abstract
To investigate the temporal expressions of IL-9 and its related cytokines after middle cerebral artery occlusion in rats. IL-9 and its related cytokines in ischemia brain and blood were tested after rats were subjected to transient focal ischemia. Comparing with sham-operated group, the levels of IL-4, TGF-β, PU.1, IRF4, OX40, NIK, RelB-p52 and IL-9 in experimental groups were significantly higher after middle cerebral artery occlusion. The results showed that expressions of IL-9 and its upstream stimulating factors increased in experimental stroke, and whether they play a role or just a secondary change is awaiting further research.
Similar content being viewed by others
References
Guan T, Liu Q, Qian Y, Yang H, Kong J, Kou J, Yu B (2013) Ruscogenin reduces cerebral ischemic injury via NF-kappaB-mediated inflammatory pathway in the mouse model of experimental stroke. Eur J Pharmacol 714:303–311
Liu L, Wang D, Wong KS, Wang Y (2011) Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke 42:3651–3654
Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819–834
Danton GH, Dietrich WD (2003) Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62:127–136
Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183:7169–7177
Chang HC, Sehra S, Goswami R et al (2010) The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11:527–534
Yao W, Tepper RS, Kaplan MH (2011) Predisposition to the development of IL-9-secreting T cells in atopic infants. J Allergy Clin Immunol 128(1357–60):e1355
Bullens DM, Kasran A, Dilissen E et al (2011) In vivo maturation of T(H) cells in relation to atopy. J Allergy Clin Immunol 128(234–7):e7
Erpenbeck VJ, Hohlfeld JM, Volkmann B et al (2003) Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 111:1319–1327
Shimbara A, Christodoulopoulos P, Soussi-Gounni A et al (2000) IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 105:108–115
Temann UA, Laouar Y, Eynon EE, Homer R, Flavell RA (2007) IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int Immunol 19:1–10
Cheng G, Arima M, Honda K (2002) Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 166:409–416
Zhao P, Xiao X, Ghobrial RM, Li XC (2013) IL-9 and Th9 cells: progress and challenges. Int Immunol 25:547–551
Murphy KM, Reiner SL (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2:933–944
Ansel KM, Djuretic I, Tanasa B, Rao A (2006) Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24:607–656
Szabo SJ, Kim ST, Costa GL et al (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655
Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852
Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775–787
Perumal NB, Kaplan MH (2011) Regulating Il9 transcription in T helper cells. Trends Immunol 32:146–150
Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91
Swanson RA, Sharp FR (1994) Infarct measurement methodology. J Cereb Blood Flow Metab 14:697–698
Zheng LF, Wang R, Xu YZ et al (2008) Calcitonin gene-related peptide dynamics in rat dorsal root ganglia and spinal cord following different sciatic nerve injuries. Brain Res 1187:20–32
Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011) Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 258:677–685
Zhou Y, Sonobe Y, Akahori T et al (2011) IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes. J Immunol 186:4415–4421
Yamasaki Y, Matsuura N, Shozuhara H et al (1995) Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676–680 (discussion 681)
Yang GY, Gong C, Qin Z et al (1998) Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. NeuroReport 9:2131–2134
Barone FC, Arvin B, White RF et al (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233–1244
Acknowledgments
This study is funded by the Role of New Th9 Cells on the Mechanism of Malignant MCA Infarction and the Change of TH9 after MSCs Implanting Ischemic Stroke Mice (No. 81271328), National Natural Science Foundation.
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Y. Lin, L. Zhang and Y. Dai contributed equally to this work.
Rights and permissions
About this article
Cite this article
Lin, Y., Zhang, L., Dai, Y. et al. Expression of interleukin-9 and its upstream stimulating factors in rats with ischemic stroke. Neurol Sci 36, 913–920 (2015). https://doi.org/10.1007/s10072-015-2096-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-015-2096-2